Shareholders Win Cert. In Suit Over Tibetan Pharma Co.'s IPO
A New Jersey federal judge on Monday granted class certification to investors claiming the parent company of a Tibetan pharmaceutical company misrepresented its financial health ahead of a 2011 initial public...To view the full article, register now.
Already a subscriber? Click here to view full article